rs121912771
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PP5_Very_Strong
The NM_000494.4(COL17A1):c.3908G>A(p.Arg1303Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000123 in 1,613,258 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000494.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL17A1 | ENST00000648076.2 | c.3908G>A | p.Arg1303Gln | missense_variant | Exon 52 of 56 | NM_000494.4 | ENSP00000497653.1 | |||
COL17A1 | ENST00000369733.8 | c.3662G>A | p.Arg1221Gln | missense_variant | Exon 47 of 51 | 5 | ENSP00000358748.3 | |||
COL17A1 | ENST00000647647.1 | n.-65G>A | upstream_gene_variant | ENSP00000497865.1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000108 AC: 27AN: 249846Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135182
GnomAD4 exome AF: 0.000120 AC: 175AN: 1460940Hom.: 1 Cov.: 33 AF XY: 0.000118 AC XY: 86AN XY: 726748
GnomAD4 genome AF: 0.000158 AC: 24AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74478
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Published functional studies demonstrate a damaging effect of the R1303Q variant on keratinocyte adhesion and collagen XVII-laminin interactions (Kroeger et al., 2019); In silico analysis, which includes splice predictors and evolutionary conservation, supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 31589614, 26604146, 9199555, 17263807, 21466533, 33393081, 23550562, 24005051, 30316981) -
- -
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1303 of the COL17A1 protein (p.Arg1303Gln). This variant is present in population databases (rs121912771, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features of junctional epidermolysis bullosa (PMID: 21466533, 23550562, 24005051, 26604146). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 17650). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on COL17A1 function (PMID: 26604146). For these reasons, this variant has been classified as Pathogenic. -
COL17A1-related disorder Pathogenic:1
The COL17A1 c.3908G>A variant is predicted to result in the amino acid substitution p.Arg1303Gln. This variant has been reported in the homozygous and compound heterozygous states in individuals with junctional epidermolysis bullosa (Schumann et al. 1997. PubMed ID: 9199555; Condrat et al. 2019. PubMed ID: 30761300; Hérissé et al. 2021. PubMed ID: 33393081). In vitro functional studies using patient keratinocytes demonstrated this variant resides in the laminin-332 binding site and results in diminished cell adhesion and impaired migration (Kroeger et al. 2018. PubMed ID: 30316981). This variant is reported in 0.026% of alleles in individuals of European (non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. -
Epidermolysis bullosa, junctional 4, intermediate Pathogenic:1
- -
Epithelial recurrent erosion dystrophy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at